Programme

The DYVS take place on Wednesdays from 16:30-17:30 via Zoom.


Upcoming seminars:
​​​​​​

22 June 2022 

Intra-host evolution of human Norovirus during chronic infections and insights into the outcome of immunoglobulin treatment

Ray Izquierdo Lara, Erasmus MC


Persistent infection of seasonal and pandemic influenza viruses in a hiPSC-derived neural model

Feline Benavides, Erasmus MC


We are always looking for enthusiastic speakers for upcoming seminars. Interested? See: KNVM Virology - Abstract submission


Past seminars:


20 April 2022 

Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns

Ilhan Tomris, Utrecht University


Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women

Ninée Buchholtz, UMC Utrecht 


16 February 2022

Non-human primate adenoviruses of the Human Adenovirus B species are potent and broadly-acting oncolytic vector candidates

Selas Bots, LUMC 


SARS-CoV-2 Omicron-specific humoral and cellular immunity in COVID-19 vaccinees

Daryl Geers, Erasmus MC 


17 November 2021 

Diversity and long-term dynamics of human blood anelloviruses

Joanna Kaczorowska, WUR 


Two-component nanoparticle vaccine displaying glycosylated SARS-CoV-2 spike S1 domain produced in insect cells

Linda van Oosten, Amsterdam UMC


20 October 2021 

mRNA vaccination boosts existing cellular responses and enhances protection against lethal H7N9 challenge in ferrets

Koen van de Ven, RIVM


Macrocyclic peptides targeting the hemagglutinin stem region potently inhibit H1 and H5 influenza A viruses

Mirte Pascha, Utrecht University 


15 September 2021 

Antiviral and immunoregulatory effects of LL-37 against dengue infection in macrophages

Jorge Andrés Castillo, UMC Groningen 


Analysis of influenza virus specific B cells reveals a diverse set of antibodies towards different domains of the influenza virus hemagglutinin

Aafke Aartse, BPRC


16 June 2021  

Identification of a novel inhibitor of Zika virus replication

Bodine Bezemer, Radboud UMC  


SARS-CoV-2 does not trigger TLR4

Lieve van der Donk, Amsterdam UMC  


19 May 2021  

Varicella-zoster virus VLT and VLT-ORF63 proteins are dispensable for lytic infection in cell culture

Shirley Braspenning, Erasmus MC


SARS-CoV-2 Infection Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins

Julia Eder, Amsterdam UMC